• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老和(此处原文缺失内容)是血浆A42水平的决定性因素。

Aging and are determinative factors of plasma A42 levels.

作者信息

Nakamura Takumi, Kawarabayashi Takeshi, Seino Yusuke, Hirohata Mie, Nakahata Naoko, Narita Sakiko, Itoh Ken, Nakaji Shigeyuki, Shoji Mikio

机构信息

Department of Neurology Hrosaki University Graduate School of Medicine 5 Zaifu-cho Hirosaki 037-8562 Japan.

Department of Stress Response Science Hirosaki University Graduate School of Medicine 5 Zaifu-cho Hirosaki 037-8562 Japan.

出版信息

Ann Clin Transl Neurol. 2018 Sep 7;5(10):1184-1191. doi: 10.1002/acn3.635. eCollection 2018 Oct.

DOI:10.1002/acn3.635
PMID:30349853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6186936/
Abstract

OBJECTIVE

The aim of this study was to confirm determinative factors for plasma A and its association with cognitive function.

METHODS

Fasting plasma A40 and A42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma A and health-related items, including physical characteristics, cognitive function tests, blood chemistry, and genotype were analyzed.

RESULTS

The plasma levels of A40 and A42, and A40/42 ratio were found to significantly increase with aging. The age-dependent increase in A42 level was significantly suppressed by . Renal function was an associated factor for the plasma A40 level. The plasma A42 level and A40/42 ratio correlated with cognitive function.

INTERPRETATION

Age and are major determinative factors of plasma levels of A42 and the A40/42 ratio. These factors are critical adjustment factors for the usage of plasma A as a biomarker of central nervous system amyloidosis.

摘要

目的

本研究旨在确定血浆A的决定性因素及其与认知功能的关联。

方法

在磐城健康促进项目的1019名参与者中,采用酶联免疫吸附测定法(ELISA)测量空腹血浆A40和A42水平。分析血浆A与健康相关指标之间的关系,包括身体特征、认知功能测试、血液化学指标和基因型。

结果

发现血浆A40和A42水平以及A40/42比值随年龄显著升高。A42水平随年龄的升高受到显著抑制。肾功能是血浆A40水平的相关因素。血浆A42水平和A40/42比值与认知功能相关。

解读

年龄和[此处原文缺失具体内容]是血浆A42水平和A40/42比值的主要决定性因素。这些因素是将血浆A用作中枢神经系统淀粉样变性生物标志物时的关键调节因素。

相似文献

1
Aging and are determinative factors of plasma A42 levels.衰老和(此处原文缺失内容)是血浆A42水平的决定性因素。
Ann Clin Transl Neurol. 2018 Sep 7;5(10):1184-1191. doi: 10.1002/acn3.635. eCollection 2018 Oct.
2
APOE-ε4 modulates the association among plasma Aβ/Aβ, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults.载脂蛋白 E-ε4 调节非痴呆老年人群血浆 Aβ/Aβ 与血管疾病、神经退行性变和认知能力下降之间的关联。
Transl Psychiatry. 2022 Mar 29;12(1):128. doi: 10.1038/s41398-022-01899-w.
3
Increased amyloid beta protein levels in children and adolescents with Down syndrome.唐氏综合征儿童和青少年中β淀粉样蛋白水平升高。
J Neurol Sci. 2007 Mar 15;254(1-2):22-7. doi: 10.1016/j.jns.2006.12.010. Epub 2007 Feb 2.
4
beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.致命性头部损伤中斑块的β-淀粉样蛋白(Aβ)42(43)、Aβ42、Aβ40和载脂蛋白E免疫染色
Neuropathol Appl Neurobiol. 2000 Apr;26(2):124-32. doi: 10.1046/j.1365-2990.2000.026002124.x.
5
Apolipoprotein E ε4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China.载脂蛋白 E ε4 等位基因与血浆淀粉样蛋白β和淀粉样蛋白β 转运体水平相关:中国西安农村地区的横断面研究。
Am J Geriatr Psychiatry. 2020 Feb;28(2):194-204. doi: 10.1016/j.jagp.2019.06.011. Epub 2019 Jun 28.
6
Annual stability of the plasma Aß40/42 ratio and associated factors.血浆 Aβ40/42 比值的年度稳定性及其相关因素。
Ann Clin Transl Neurol. 2023 Jun;10(6):879-891. doi: 10.1002/acn3.51770. Epub 2023 Apr 4.
7
Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.载脂蛋白E基因型与阿尔茨海默病中β淀粉样蛋白40和β淀粉样蛋白42的沉积
Arch Neurol. 1998 Jul;55(7):1001-4. doi: 10.1001/archneur.55.7.1001.
8
The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.血浆 Aβ 水平与轻度认知障碍老年人痴呆的关系。
J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005. Epub 2011 Mar 26.
9
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
10
Non-linear Relationship Between Plasma Amyloid-β 40 Level and Cognitive Decline in a Cognitively Normal Population.认知正常人群中血浆淀粉样蛋白β40水平与认知衰退之间的非线性关系
Front Aging Neurosci. 2020 Sep 11;12:557005. doi: 10.3389/fnagi.2020.557005. eCollection 2020.

引用本文的文献

1
Effects of Diminished Cerebrospinal Fluid Flow in the Spinal Canal on Amyloid Pathophysiology in Vervet Monkeys.脊髓管内脑脊液流动减少对绿猴淀粉样蛋白病理生理学的影响。
Res Sq. 2025 May 13:rs.3.rs-6551242. doi: 10.21203/rs.3.rs-6551242/v1.
2
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review.脑淀粉样血管病的血浆生物标志物及其对淀粉样相关影像学异常的影响:综述
J Clin Med. 2025 Feb 7;14(4):1070. doi: 10.3390/jcm14041070.
3
Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults.

本文引用的文献

1
High performance plasma amyloid-β biomarkers for Alzheimer's disease.用于阿尔茨海默病的高性能血浆淀粉样蛋白-β生物标志物。
Nature. 2018 Feb 8;554(7691):249-254. doi: 10.1038/nature25456. Epub 2018 Jan 31.
2
Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1-42 in Alzheimer's Disease Neuroimaging Initiative participants.阿尔茨海默病神经影像学计划参与者中的2型糖尿病与脑脊液阿尔茨海默病生物标志物β淀粉样蛋白1-42
Alzheimers Dement (Amst). 2017 Nov 23;10:94-98. doi: 10.1016/j.dadm.2017.11.002. eCollection 2018.
3
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals.
血浆淀粉样蛋白-β与黑人和白人老年人群痴呆的相关性。
J Alzheimers Dis. 2024;99(2):787-797. doi: 10.3233/JAD-240007.
4
Annual stability of the plasma Aß40/42 ratio and associated factors.血浆 Aβ40/42 比值的年度稳定性及其相关因素。
Ann Clin Transl Neurol. 2023 Jun;10(6):879-891. doi: 10.1002/acn3.51770. Epub 2023 Apr 4.
5
Deep transfer learning of structural magnetic resonance imaging fused with blood parameters improves brain age prediction.深度迁移学习融合结构磁共振成像与血液参数可提高脑龄预测。
Hum Brain Mapp. 2022 Apr 1;43(5):1640-1656. doi: 10.1002/hbm.25748. Epub 2021 Dec 16.
6
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.采用 AD 生物标志物 5 阶段开发框架评估淀粉样蛋白和磷酸化 tau 血液生物标志物的验证状态。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156. doi: 10.1007/s00259-021-05253-y. Epub 2021 Mar 6.
7
Aβ misfolding in blood plasma measured by immuno-infrared-sensor as an age-independent risk marker of Alzheimer's disease.通过免疫红外传感器测量血浆中β淀粉样蛋白错误折叠作为阿尔茨海默病与年龄无关的风险标志物。
Alzheimers Dement (Amst). 2021 Feb 10;13(1):e12151. doi: 10.1002/dad2.12151. eCollection 2021.
8
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms?载脂蛋白 E 多态性与人类外周血细胞中的氧化应激:体育活动能否通过表观遗传机制重新激活蛋白酶体系统?
Oxid Med Cell Longev. 2021 Jan 2;2021:8869849. doi: 10.1155/2021/8869849. eCollection 2021.
9
Quantitative Measurement of Cerebrospinal Fluid Amyloid-β Species by Mass Spectrometry.采用质谱法对脑脊髓液淀粉样蛋白-β 进行定量测量。
J Alzheimers Dis. 2021;79(2):573-584. doi: 10.3233/JAD-200987.
10
Plasma Biomarkers of Alzheimer's Disease in African Americans.非裔美国人阿尔茨海默病的血浆生物标志物。
J Alzheimers Dis. 2021;79(1):323-334. doi: 10.3233/JAD-200828.
血浆淀粉样蛋白β42/40比值作为认知正常个体脑淀粉样蛋白β沉积的生物标志物。
Alzheimers Dement (Amst). 2017 Sep 12;8:179-187. doi: 10.1016/j.dadm.2017.07.004. eCollection 2017.
4
genotype and early β-amyloid accumulation in older adults without dementia.老年非痴呆人群的基因型与早期β-淀粉样蛋白积聚
Neurology. 2017 Sep 5;89(10):1028-1034. doi: 10.1212/WNL.0000000000004336. Epub 2017 Aug 9.
5
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.针对中枢神经系统淀粉样变性的人血浆淀粉样蛋白β浓度及稳定同位素标记动力学
Alzheimers Dement. 2017 Aug;13(8):841-849. doi: 10.1016/j.jalz.2017.06.2266. Epub 2017 Jul 19.
6
Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study.胆固醇暴露与神经病理学发现的关联:ACT 研究。
J Alzheimers Dis. 2017;59(4):1307-1315. doi: 10.3233/JAD-161224.
7
Physical activity predicts reduced plasma amyloid in the Cardiovascular Health Study.在心血管健康研究中,身体活动预示着血浆淀粉样蛋白水平降低。
Ann Clin Transl Neurol. 2017 Apr 14;4(5):284-291. doi: 10.1002/acn3.397. eCollection 2017 May.
8
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.血浆中游离淀粉样蛋白β的浓度不能预测阿尔茨海默病的发展。
Alzheimers Dement. 2017 Jul;13(7):778-782. doi: 10.1016/j.jalz.2016.12.004. Epub 2017 Jan 7.
9
Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.β-淀粉样蛋白在中枢神经系统中的动力学与昼夜节律的相关性研究。
JAMA Neurol. 2017 Feb 1;74(2):207-215. doi: 10.1001/jamaneurol.2016.4202.
10
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用:系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.